National Pension Service Purchases 10,678 Shares of McKesson Corporation $MCK

National Pension Service increased its holdings in shares of McKesson Corporation (NYSE:MCK) by 2.8% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 387,456 shares of the company’s stock after purchasing an additional 10,678 shares during the period. National Pension Service’s holdings in McKesson were worth $299,325,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently made changes to their positions in the company. CW Advisors LLC increased its position in McKesson by 282.5% during the 2nd quarter. CW Advisors LLC now owns 11,008 shares of the company’s stock valued at $8,067,000 after purchasing an additional 8,130 shares during the period. Voya Investment Management LLC increased its stake in McKesson by 11.9% during the 3rd quarter. Voya Investment Management LLC now owns 598,880 shares of the company’s stock valued at $462,126,000 after purchasing an additional 63,621 shares in the last quarter. Central Pacific Bank Trust Division boosted its stake in McKesson by 54.4% during the 3rd quarter. Central Pacific Bank Trust Division now owns 3,913 shares of the company’s stock valued at $3,023,000 after purchasing an additional 1,378 shares during the last quarter. Motco grew its stake in shares of McKesson by 50,389.7% in the 3rd quarter. Motco now owns 14,642 shares of the company’s stock worth $11,312,000 after acquiring an additional 14,613 shares in the last quarter. Finally, Generate Investment Management Ltd increased its position in shares of McKesson by 138.4% during the third quarter. Generate Investment Management Ltd now owns 20,267 shares of the company’s stock valued at $15,657,000 after acquiring an additional 11,765 shares during the last quarter. Institutional investors own 85.07% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on MCK. Jefferies Financial Group increased their target price on shares of McKesson from $820.00 to $900.00 and gave the company a “buy” rating in a research report on Monday, October 13th. Zacks Research downgraded McKesson from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 25th. UBS Group lifted their price target on McKesson from $920.00 to $980.00 and gave the stock a “buy” rating in a research note on Thursday, November 6th. Morgan Stanley restated an “overweight” rating and issued a $966.00 price objective on shares of McKesson in a report on Thursday. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of McKesson in a report on Wednesday, December 10th. Two research analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $899.36.

Insider Buying and Selling at McKesson

In related news, EVP Thomas L. Rodgers sold 276 shares of McKesson stock in a transaction on Monday, January 5th. The stock was sold at an average price of $816.18, for a total transaction of $225,265.68. Following the transaction, the executive vice president directly owned 2,268 shares in the company, valued at approximately $1,851,096.24. The trade was a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Napoleon B. Rutledge, Jr. sold 329 shares of McKesson stock in a transaction dated Friday, November 7th. The shares were sold at an average price of $861.63, for a total value of $283,476.27. Following the transaction, the chief accounting officer directly owned 328 shares in the company, valued at approximately $282,614.64. The trade was a 50.08% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.08% of the stock is currently owned by insiders.

McKesson Price Performance

MCK opened at $831.32 on Friday. McKesson Corporation has a 1 year low of $570.51 and a 1 year high of $895.58. The firm has a market cap of $102.61 billion, a PE ratio of 25.87, a P/E/G ratio of 1.35 and a beta of 0.41. The stock has a 50-day moving average price of $828.09 and a 200-day moving average price of $773.56.

McKesson (NYSE:MCK) last released its quarterly earnings data on Wednesday, November 5th. The company reported $9.86 EPS for the quarter, topping the consensus estimate of $8.84 by $1.02. McKesson had a negative return on equity of 248.14% and a net margin of 1.04%.The company had revenue of $103.15 billion during the quarter, compared to the consensus estimate of $103.80 billion. During the same period last year, the company earned $7.07 EPS. McKesson’s revenue for the quarter was up 10.2% on a year-over-year basis. As a group, sell-side analysts anticipate that McKesson Corporation will post 32.77 EPS for the current year.

McKesson Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be issued a $0.82 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. McKesson’s dividend payout ratio (DPR) is presently 10.21%.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.